[1]
|
Zhou, R., Ma, P., Xiong, A., et al. (2017) Protective Effects of Low-Dose Rosuvastatin on Isoproterenol-Induced Chronic Heart Failure in Rats by Regulation of DDAH-ADMA-NO Pathway. Cardiovascular Therapeutics, 35, e12241. https://doi.org/10.1111/1755-5922.12241
|
[2]
|
Tendera, M. (2005) Epidemiology, Treatment, and Guidelines for the Treatment of Heart Failure in Europe. European Heart Journal Supplements, 7, J5-J9. https://doi.org/10.1093/eurheartj/sui056
|
[3]
|
吕国伟. 高血压患者血清胱抑素C与冠心病的关系[D]: [硕士学位论文]. 郑州: 郑州大学, 2013.
|
[4]
|
Lassus, J. and Harjola, V.P. (2012) Cystatin C: A Step forward in Assessing Kidney Function and Cardiovascular Risk. Heart Failure Reviews, 17, 251-261. https://doi.org/10.1007/s10741-011-9242-6
|
[5]
|
Deo, R., Fyr, C.L., Fried, L.F., et al. (2008) Kidney Dysfunction and Fatal Cardiovascular Disease—An Association Independent of Atheroselemtic (Health ABC) Study. American Heart Journal, 155, 62-68. https://doi.org/10.1016/j.ahj.2007.08.012
|
[6]
|
Barka, T. and vander Noen, H. (1993) Expression of the Eysteine Proteinase Inhibitor Cystatin C Gene in Rat Heart: Use of Digoxigenin-Labeled Probes Generated by Polymerase Chain reaction Directly for in Situ and Northern Blot Hybridizations. Journal of Histochemistry & Cytochemistry, 41, 1863-1867. https://doi.org/10.1177/41.12.8245434
|
[7]
|
Ix, J.H., Shlipak, M.G., Cheaow, G.M., et al. (2006) Cystatin C, Left Ventricular Hypertrophy and Diastolic Dysfunction: Data from the Heart and Soul Study. Journal of Cardiac Failure, 12, 601-607. https://doi.org/10.1016/j.cardfail.2006.07.005
|
[8]
|
Patel, P.C., Ayers, C.R., Murphy, S.A., et al. (2009) Association of Cystatin C with Left Ventricular Structure and Function: The Dallas Heart Study. Circulation: Heart Failure, 2, 98-104. https://doi.org/10.1161/CIRCHEARTFAILURE.108.807271
|
[9]
|
Lok, D.J., Lok, S.I., Badings, E., et al. (2013) Galectin-3 Is an Independent Marker for Ventricular Remodeling and Mortality in Patients with Chronic Heart Failure. Clinical Research in Cardiology, 102, 103-110. https://doi.org/10.1007/s00392-012-0500-y
|
[10]
|
刘巍, 郑蕊. 血胱抑素测定在临床诊断中的应用[J]. 中国民康医学, 2009, 21(18): 2291-2291.
|
[11]
|
刘海燕, 李伟娜, 肖波, 等. 胱抑素C临床检验及在肾脏疾病应用中的研究进展[J]. 河北医药, 2015, 37(21): 3311-3315.
|
[12]
|
Elshafey, E.M., Elnagar, G.F., Selim, M.F., et al. (2009) Is Serum Cystatin C an Accurate Endogenous Marker of Glomerular Filteration Rate for Detection of Early Renal Impairment in Patients with Type 2 Diabetes Mellitus? Renal Failure, 31, 355-359. https://doi.org/10.1080/08860220902839089
|
[13]
|
Christensson, A., Ekberg, J., Grubb, A., et al. (2003) Serum Cystatin C Is a More Sensitive and More Accurate Marker of Glomerular Filtration Rate than Enzymatic Measurements of Creatinine in Renal Transplantation. Nephron Physiology, 94, 19-27. https://doi.org/10.1159/000071287
|
[14]
|
Perkins, B.A., Nelson, R.G., Ostrander, B.E.P., et al. (2005) Detection of Renal Function Decline in Patients with Diabetes and Normal or Elevated GFR by Serial Measurements of Serum Cystatin C Concentration: Results of a 4-Year Follow-Up Study. Journal of the American Society of Nephrology, 16, 1404-1412. https://doi.org/10.1681/ASN.2004100854
|
[15]
|
Wang, Y., Su, X., Zhang, W., et al. (2015) Correlation between Serum Cystatin C Level and Elderly Hypertensive Patients Combined Coronary Heart Disease. International Journal of Clinical & Experimental Medicine, 8, 6287-6290.
|
[16]
|
Petrovic, D. (2004) Cytopathological Basis of Heart Failure-Cardiomyocyte Apoptosis, Interstitial Fibrosis and Inflammatory Cell Response. Folia Biologica, 50, 58-62.
|
[17]
|
Jugdutt, B.I. (2003) Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways. Current Drug Targets—Cardiovascular & Hematological Disorders, 3, 1-30. https://doi.org/10.2174/1568006033337276
|
[18]
|
Medvedev, N.V. and Gorshunova, N.K. (2014) Apoptosis and Interstitial Fibrosis in Remodeling of the Myocardium in Elderly Patients with Arterial Hypertension. Advances in Gerontology, 4, 46-50. https://doi.org/10.1134/S2079057014010056
|
[19]
|
Shimoyama, N., Maeda, T., Inoue, T., Niwa, H. and Saikawa, T. (1993) Serum Thyroid Hormone Levels Correlate with Cardiac Function and Ventricular Tachyarrhythmia in Patients with Chronic Heart Failure. Journal of Cardiology, 23, 205-213.
|
[20]
|
Ix, J.H., Shlipak, M.G., Chertow, G.M. and Whooley, M.A. (2007) Association of Cystatin C with Mortality, Cardiovascular Events, and Incident Heart Failure among Persons with Coronary Heart Disease: Data From the Heart and Soul Study. Circulation, 115, 173-179. https://doi.org/10.1161/CIRCULATIONAHA.106.644286
|
[21]
|
Arimoto, T., Takeishi, Y., Niizeki, T., et al. (2005) Cystatin C, a Novel Measure of Renal Function, Is an Independent Predictor of Cardiac Events in Patients with Heart Failure. Journal of Cardiac Failure, 11, 595-601. https://doi.org/10.1016/j.cardfail.2005.06.001
|